A new study conducted by researchers at The Scripps Research Institute suggests that an existing Parkinson’s disease drug may provide an effective new therapy for Multiple sclerosis. These findings were published in Nature.

The recent book by NNN members Tormod Fladby and Leif Gjerstad discusses several important aspects of dementia.

Nansen Neuroscience Network, The Norwegian Research Council, Oslo Medtech and Oslo Cancer Cluster are happy to invite companies and researchers to an information meeting on Horizon 2020 Health, the Innovative Medicines Initiative (IMI) and Active and Assisted Living (AAL). 

Thursday the 17th of October Nansen Neuroscience Network organized the meeting #demens2013 – Kan vi løse demensgåten? at the University of Oslo. About 120 participants were gathered. 

On October 17th, Nansen Neuroscience Network published the report “Næring for hjernen”. The report contains an overview of Norwegian research and development on dementia disorders, as well as an analysis of what it will take to translate the research into new diagnostics and treatments that will benefit patients.

The NNN report "Næring for hjernen" was presented at our National symposium on dementia on October 17th. The report contains an overview of dementia-related medical research and development in Norway. The report brought much media attention to NNN and the importance of further research and development.

The International Multiple Sclerosis Genetics Consortium (IMSGC) conducted this study, which is an international collaboration between researchers from across the world. Six Norwegian researchers were involved.

The focus was on neuroimaging and its clinical applications when Norwegian and international researchers met at the fMRI symposium in Bergen. 

Pages